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SHORT COMMUNICATION
Bipolar disorder in the digital age: new 
tools for the same illness
John Torous1,2*, Paul Summergrad3 and S. Nassir Ghaemi3
Abstract 
“Nothing is more difficult than to ascertain the length of time that a maniacal patient can exist without sleep.”—Dr. 
Sutherland (Br J Psychiatry 7(37):1–19, 1861). Dr. Sutherland’s patient was suffering from an acute manic episode, 
which today is called bipolar illness. 150 years later, we continue to struggle with the same challenges in ascertaining 
accurate symptoms from patients. In era of new digital tools, the quantified self-movement, and precision medicine, 
we can ask the question: Can we advance understanding and treatment for bipolar illness beyond asking the same 
questions as in 1861?
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Notecards
The greatest breakthrough in understanding this dis-
ease did not require any technology at all. Dr. Sutherland 
would have offered his patient the only diagnosis that 
existed at the time: insanity. A few decades later, the Ger-
man psychiatrist Emil Kraepelin began a series of careful 
observations utilizing notecards to longitudinally assess 
symptoms and outcomes in insane hospitalized patients. 
Years of carefully collected data revealed at least two 
major different courses of illness, with one group remain-
ing delusional all the time, and never improving, while 
another had time-limited episodes of delusions, with 
eventual recovery, followed by later relapse. The resulting 
conceptualization of manic-depressive insanity (MDI), 
as Kraepelin defined it, was distinguished from demen-
tia praecox (later revised by others to “schizophrenia”), 
thus breaking down the broad label of insanity into two 
different illnesses (Torous and Keshavan 2014). This dis-
tinction continues to have considerable clinical salience, 
despite heavy criticism over the past century. In the last 
40 years, the broad manic-depressive concept was rede-
fined in DSM-III in 1980 to a narrower bipolar disorder 
concept and a much broader major depressive disorder 
(MDD) concept (Decker 2007). Bipolar illness, as the 
term is now used in the DSM-5 (Angst 2013), is not the 
same thing as MDI, but is rather smaller part of the lat-
ter. Contrary to common belief, Kraepelin’s original view 
of MDI did not involve “classic episodic” bipolar disorder, 
but rather the reverse: he held that mixed states were the 
most common mood state, and polarity was irrelevant to 
diagnosis: what are now called “unipolar” depressive epi-
sodes were viewed by Kraepelin as part of MDI (Ghaemi 
and Dalley 2014). Nonetheless, much of Kraepelin’s 
observations have been retained, though revised, in the 
bipolar and MDD constructs (Duffy et al. 2016).
Kraepelin’s innovation was based on a simple kind of 
technology, the use of note cards and the application of 
basic statistical enumeration: counting. Such great suc-
cess with such basic methods suggests that other tech-
nology and methods might have a larger potential. A 
particular question is what may be the impact of today’s 
digital devices which are capable of measuring much 
more data, and of different types than Kraepelin or other 
more recent researchers could ever have imagined.
Digital technology
Despite this potential, initial studies with digital tech-
nologies for monitoring or augmented diagnosis in bipo-
lar illness have not yielded anything near the profound 
results that Kraepelin achieved with his simple notecards. 
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Actigraphy research, broadly defined as the use of non-
invasive tools to measure human behavior and patterns, 
has suggested that patients with bipolar illness are willing 
to wear custom watches to detect sleep and activity pat-
terns, and even wear t-shirts with embedded cardiac sen-
sors (Migliorini et al. 2011). But nothing near a diagnostic 
breakthrough is likely to occur because of adherence 
issues. Considering actigraphy for patients with bipo-
lar illness, one study observed that the “system requires 
a large number of sensors and devices… result[ing] in 
user rejection of the system altogether” (Prociow et  al. 
2012). Kraepelin was able to obtain long-term careful 
observation of patients because they were confined to 
state hospitals for years. Today, hospitalizations are very 
brief, usually a week or so in length, and patients treated 
outside hospitals, in clinical settings, are both unlikely to 
wear special sensors or devices for extended periods of 
time, and may experience such techniques as an intru-
sion on their privacy. It appears that actigraphy will not 
be able to provide valuable long-term longitudinal data 
needed to advance understanding of bipolar illness.
The recent rise of smartphones has rekindled interest in 
actigraphy, especially for bipolar illness, and there is hope 
that these devices and their related apps may finally yield 
valuable clinical information that may aid in diagnosis 
and monitoring. Like everyone else, people with bipolar 
illness increasingly own and use smartphones and other 
connected devices. Smartphones and many wearables are 
able to collect data, such as location via GPS sensors and 
voice data from conversations and social metrics, via call 
and text logs—all without the user taking any additional 
action (Faurholt-Jepsen et al. 2016; Abdullah et al. 2016). 
These features raise the possibility that adherence to data 
collection will be less of obstacle as with actigraphy. Yet 
early research using smartphones to record symptoms 
of bipolar illness has been equivocal. This is likely in 
part due to the early nature of this research with many 
studies small in sample size and not randomized or even 
controlled (Kaplan and Stone 2013). Detecting state tran-
sitions to mania and depression may require large-scale 
longitudinal studies. Some symptoms should be easier to 
assess than others. Sutherland’s focus on sleep, which is 
among the most objective of manic symptoms, should be 
the easiest question to solve. Smartphones already pro-
vide extensive data on sleep patterns. There is promise 
that they can characterize the nature of manic insomnia, 
if we apply them to systematic research on bipolar illness. 
But other aspects of the manic syndrome seem to be 
more difficult to explore, with new data streams that are 
complex and often difficult to interpret (Monteith et  al. 
2015; Faurholt-Jepsen et al. 2015).
How can it be that in this age where we can collect so 
much information from patients, more than one mil-
lion data points per day from smartphones (Torous et al. 
2016; Monteith et  al. 2016), we still cannot rival the 
results and insights of Kraepelin’s notecards?
Back to Kraepelin
There is no simple answer to this question, but two 
features of Kraepelin’s work may suggest possible solu-
tions. First, he did not set out to determine how well his 
notecard data could match the then current concept of 
insanity. Rather than trying to fit his data to the conven-
tional nosology of his time, he let the data guide him 
towards a new nosology. Second, he made his observa-
tions over years, in some cases decades, before draw-
ing conclusions about the meaning of the data. Today, 
studies are usually short in duration, often only a few 
weeks and rarely longer than a year. Grant funders and 
researchers today are impatient; the concept of long-
term outcome is rarely funded or studied in psychiatry, 
with the longest randomized clinical trials routinely 
being one year at most. There is no inherent reason why 
this should be the case. We note that cardiology stud-
ies, even in complex double-blind randomized trials, 
commonly are conducted for five years or longer. Yet we 
make diagnoses that last a lifetime, and we give medica-
tions for decades.
These observations suggest a new insight: Perhaps our 
digital tools are fine, even excellent in the purely techni-
cal sense. Our problem is that we are not applying them 
effectively or thoughtfully.
To follow Kraepelin’s example, we would need the 
courage, while starting with clinically defined popula-
tions to allow the longitudinal data to guide diagnostic 
definitions, rather than the other way around. We also 
would need to slow down the process, and obtain data for 
longer periods, rather than weeks or months, and from 
much larger groups of patients and controls, before draw-
ing meaningful conclusions. New statistical methods are 
also need to make sense of the large amount of data col-
lected (Torous et al. 2015). We also need to be thoughtful 
about how we employ these technologies. The foundation 
of health is trust, and thus there must be more empha-
sis on transparency and data security. More focus on the 
user perspective and design will likely increase adherence 
and acceptance.
We have the technology. Now we have find methods 
to collect data which can be acceptable to patients, fam-
ily members, IRBs, and the general public, especially 
considering the continued stigma associated with psy-
chiatric illnesses, and the not insubstantial concerns 
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that have been raised about the safety and privacy of 
digital data. Maintaining confidentiality of such vast 
amounts of longitudinal data will require more than 
just digital safeguards with a need to also focus train-
ing on people, processes, and regulations surrounding 
such sensitive information (Armontrout et  al. 2016). It 
will also require us to be open, as in all good research to 
where the findings take us. This requires a scientific atti-
tude of self-criticism and openness to change, as well as 
demonstrating the superiority or at least the non-inferi-
ority of such data in assessing and caring for real-world 
patients.
It is time to make use of our powerful new technolo-
gies, but to do so, we have to prepare our minds to use 
those technologies most effectively, and to think through 
carefully both the ethical and methodological issues at 
hand. It will also require funding streams that are not 
driven by quarter-to-quarter market results. In the end, 
it may also be that the mentality of the note taker matters 
as much as the use of the notecard.
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